Blocking EFGR significantly inhibited the uPAR and MMP-9 induced EGFR and STAT3 activation in medulloblastoma cells compared to the cells treated with the isotype IgG (Fig. 5A). The gene discussed is EGFR; the disease is medulloblastoma.